Research | OneLook Acronym Finder |
Serial Number | 90322013 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Anessa Owen Kramer |
Attorney Docket Number | 224143481405 |
2020-11-16 | Application Filed |
2020-11-19 | Location: NEW APPLICATION PROCESSING |
2020-11-19 | Status: Live/Pending |
2020-11-20 | Transaction Date |
Owner: | GW Research Limited |
Entity Statement | private limited company |
Address | Sovereign House, Vision Park Chivers Way, Histon Cambridge GB CB249BZ |
Legal Entity Type | |
Legal Entity State | GB |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical and veterinary preparations and substances; pharmaceutical preparations and substances for the treatment of neurological conditions, disorders and diseases; pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, oncology, cancer symptoms, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, neurogenic symptoms, movement disorders, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, post-traumatic stress disorders, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's disease, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders, sleep and sleep disorders; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions; pure extracts of medicinal plants and herbs; foodstuffs for medicinal purposes; herb teas for medicinal purposes; plant extracts for pharmaceutical purposes |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2020-11-19 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-01-15 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2021-04-26 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2021-05-03 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2021-05-03 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-05-03 | 6 GNRN O:Outgoing Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-09-15 | 7 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-09-15 | 8 ARAA I:Incoming Correspondence |
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | 2021-09-15 | 9 ECDR I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-09-15 | 10 TCCA I:Incoming Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-11-01 | 11 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-11-01 | 12 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-11-02 | 13 TEME I:Incoming Correspondence |
EXAMINERS AMENDMENT -WRITTEN | 2021-11-14 | 14 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2021-11-14 | 15 GNEA O:Outgoing Correspondence |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-11-14 | 16 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2021-11-14 | 17 XAEC I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-11-15 | 18 CNSA P: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-12-01 | 19 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2021-12-21 | 20 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-12-21 | 21 NPUB E:E-Mail |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2022-02-15 | 22 NOAM E:E-Mail |
TEAS EXTENSION RECEIVED | 2022-08-08 | 23 EEXT I:Incoming Correspondence |
SOU EXTENSION 1 FILED | 2022-08-08 | 24 EXT1 S: |
SOU EXTENSION 1 GRANTED | 2022-08-08 | 25 EX1G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2022-08-10 | 26 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2023-02-15 | 27 EEXT I:Incoming Correspondence |
SOU EXTENSION 2 FILED | 2023-02-15 | 28 EXT2 S: |
SOU EXTENSION 2 GRANTED | 2023-02-15 | 29 EX2G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-02-17 | 30 EXRA E:E-Mail |
TEAS EXTENSION RECEIVED | 2023-07-13 | 31 EEXT I:Incoming Correspondence |
SOU EXTENSION 3 FILED | 2023-07-13 | 32 EXT3 S: |
SOU EXTENSION 3 GRANTED | 2023-07-13 | 33 EX3G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-07-15 | 34 EXRA E:E-Mail |
SOU TEAS EXTENSION RECEIVED | 2024-01-18 | 35 EEXT I:Incoming Correspondence |
SOU EXTENSION 4 FILED | 2024-01-18 | 36 EXT4 S: |
SOU EXTENSION 4 GRANTED | 2024-01-18 | 37 EX4G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2024-01-20 | 38 EXRA E:E-Mail |
SOU TEAS EXTENSION RECEIVED | 2024-08-01 | 39 EEXT I:Incoming Correspondence |
SOU EXTENSION 5 FILED | 2024-08-01 | 40 EXT5 S: |
SOU EXTENSION 5 GRANTED | 2024-08-01 | 41 EX5G S: |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2024-08-01 | 42 EXRA E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.